Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Chemotherapy: maintenance rituximab for relapsed follicular lymphoma.

× No keyword cloud information.

8 in total

1. Rituximab maintenance treatment of relapsed/resistant follicular non-Hodgkin's lymphoma: long-term outcome of the EORTC 20981 phase III randomized intergroup study.

Authors: Marinus H J van Oers; Martine Van Glabbeke; Livia Giurgea; Richard Klasa; Robert E Marcus; Max Wolf; Eva Kimby; Mars van t Veer; Andrej Vranovsky; Harald Holte; Anton Hagenbeek
Journal: J Clin Oncol Date: 2010-05-03 Impact factor: 44.544

2. Long-term follow-up of patients with newly diagnosed follicular lymphoma in the prerituximab era: effect of response quality on survival--A study from the groupe d'etude des lymphomes de l'adulte.

Authors: Emmanuel Bachy; Pauline Brice; Richard Delarue; Nicole Brousse; Corinne Haioun; Steven Le Gouill; Alain Delmer; Dominique Bordessoule; Hervé Tilly; Bernadette Corront; Christian Allard; Charles Foussard; André Bosly; Bertrand Coiffier; Christian Gisselbrecht; Philippe Solal-Celigny; Gilles Salles
Journal: J Clin Oncol Date: 2009-12-21 Impact factor: 44.544

3. T-cell-depleted reduced-intensity transplantation followed by donor leukocyte infusions to promote graft-versus-lymphoma activity results in excellent long-term survival in patients with multiply relapsed follicular lymphoma.

Authors: Kirsty J Thomson; Emma C Morris; Don Milligan; Anne N Parker; Ann E Hunter; Gordon Cook; Adrian J C Bloor; Fiona Clark; Majid Kazmi; David C Linch; Ronjon Chakraverty; Karl S Peggs; Stephen Mackinnon
Journal: J Clin Oncol Date: 2010-07-06 Impact factor: 44.544

4. Phase III study of R-CVP compared with cyclophosphamide, vincristine, and prednisone alone in patients with previously untreated advanced follicular lymphoma.

Authors: Robert Marcus; Kevin Imrie; Philippe Solal-Celigny; John V Catalano; Anna Dmoszynska; João C Raposo; Fritz C Offner; José Gomez-Codina; Andrew Belch; David Cunningham; Elisabeth Wassner-Fritsch; George Stein
Journal: J Clin Oncol Date: 2008-07-28 Impact factor: 44.544

5. Rituximab combined with chemotherapy and interferon in follicular lymphoma patients: results of the GELA-GOELAMS FL2000 study.

Authors: Gilles Salles; Nicolas Mounier; Sophie de Guibert; Franck Morschhauser; Chantal Doyen; Jean-François Rossi; Corinne Haioun; Pauline Brice; Béatrice Mahé; Reda Bouabdallah; Bruno Audhuy; Christophe Ferme; Caroline Dartigeas; Pierre Feugier; Catherine Sebban; Luc Xerri; Charles Foussard
Journal: Blood Date: 2008-09-17 Impact factor: 22.113

6. Follicular lymphoma in the United States: first report of the national LymphoCare study.

Authors: Jonathan W Friedberg; Michael D Taylor; James R Cerhan; Christopher R Flowers; Hildy Dillon; Charles M Farber; Eric S Rogers; John D Hainsworth; Elaine K Wong; Julie M Vose; Andrew D Zelenetz; Brian K Link
Journal: J Clin Oncol Date: 2009-02-09 Impact factor: 44.544

7. Myeloablative therapy with autologous bone marrow transplantation for follicular lymphoma at the time of second or subsequent remission: long-term follow-up.

Authors: Ama Z S Rohatiner; Lee Nadler; Andrew J Davies; John Apostolidis; Donna Neuberg; Janet Matthews; John G Gribben; Peter M Mauch; T Andrew Lister; Arnold S Freedman
Journal: J Clin Oncol Date: 2007-05-21 Impact factor: 44.544

8. Patterns of survival in patients with recurrent follicular lymphoma: a 20-year study from a single center.

Authors: P W Johnson; A Z Rohatiner; J S Whelan; C G Price; S Love; J Lim; J Matthews; A J Norton; J A Amess; T A Lister
Journal: J Clin Oncol Date: 1995-01 Impact factor: 44.544

8 in total